CORINALDESI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 13.075
AS - Asia 10.537
EU - Europa 8.685
AF - Africa 591
SA - Sud America 508
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 33.432
Nazione #
US - Stati Uniti d'America 12.952
VN - Vietnam 3.225
SG - Singapore 2.675
CN - Cina 2.613
GB - Regno Unito 2.342
IT - Italia 1.381
DE - Germania 1.246
SE - Svezia 775
HK - Hong Kong 743
UA - Ucraina 600
FR - Francia 528
IN - India 457
RU - Federazione Russa 405
BR - Brasile 355
FI - Finlandia 298
IE - Irlanda 298
CH - Svizzera 210
JP - Giappone 179
NL - Olanda 171
ZA - Sudafrica 142
EE - Estonia 137
KR - Corea 137
TG - Togo 131
CI - Costa d'Avorio 115
NG - Nigeria 96
JO - Giordania 82
PH - Filippine 75
AT - Austria 70
CA - Canada 68
AR - Argentina 60
BG - Bulgaria 55
SC - Seychelles 53
TH - Thailandia 49
BE - Belgio 35
IQ - Iraq 35
BD - Bangladesh 34
ID - Indonesia 34
AU - Australia 29
MX - Messico 29
TW - Taiwan 29
IR - Iran 28
EC - Ecuador 27
PL - Polonia 27
TR - Turchia 27
GR - Grecia 23
PK - Pakistan 20
SA - Arabia Saudita 19
CL - Cile 18
HR - Croazia 16
UZ - Uzbekistan 15
CO - Colombia 13
LB - Libano 13
ES - Italia 12
RO - Romania 12
PY - Paraguay 11
TN - Tunisia 11
EG - Egitto 10
LT - Lituania 10
MA - Marocco 10
MY - Malesia 9
PE - Perù 9
CZ - Repubblica Ceca 8
DZ - Algeria 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
VE - Venezuela 6
GH - Ghana 5
HU - Ungheria 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
JM - Giamaica 4
NP - Nepal 4
OM - Oman 4
SV - El Salvador 4
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
KW - Kuwait 3
NI - Nicaragua 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
PA - Panama 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
Totale 33.413
Città #
Southend 2.079
Houston 1.995
Singapore 1.803
Ashburn 1.177
Fairfield 1.012
Dong Ket 868
Chandler 769
Hong Kong 690
San Jose 558
Ho Chi Minh City 544
Santa Clara 544
Hanoi 521
Woodbridge 508
Wilmington 464
Seattle 460
Jacksonville 395
Princeton 385
Ann Arbor 352
Cambridge 350
Hefei 335
Beijing 329
Munich 310
Dublin 294
Helsinki 261
Boardman 258
Bern 190
Los Angeles 184
New York 181
Padova 181
Lauterbourg 171
Westminster 168
Nanjing 167
Tokyo 138
Berlin 136
Bologna 132
Lomé 131
Milan 128
Abidjan 115
Seoul 105
Jinan 96
Buffalo 92
Shenyang 86
Amman 81
Haiphong 76
Changsha 75
Guangzhou 75
Saint Petersburg 75
Mülheim 73
Da Nang 72
Bremen 69
Dallas 68
Abeokuta 64
Rome 61
Shanghai 59
Tianjin 59
San Diego 58
Medford 57
Nanchang 54
Sofia 54
Hebei 50
Florence 49
Washington 49
Vienna 46
Turin 44
Frankfurt am Main 43
Redondo Beach 43
São Paulo 42
Mahé 40
Dearborn 39
Bengaluru 38
Haikou 37
Yubileyny 35
Council Bluffs 34
Falls Church 34
Phoenix 34
Des Moines 33
Verona 32
Zhengzhou 32
Hyderabad 31
Toronto 31
Hangzhou 30
Ningbo 30
Brussels 28
Hải Dương 27
Shenzhen 26
Biên Hòa 25
Falkenstein 25
Orem 25
Jiaxing 24
Lagos 24
Norwalk 24
Taizhou 24
Fuzhou 23
London 23
Bắc Ninh 22
Can Tho 22
Chicago 22
Amsterdam 21
Kunming 21
Olalla 20
Totale 22.094
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.815
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 552
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 424
Chronic Intestinal Pseudo-Obstruction: A Neuropathological Approach 362
La sindrome dell'intestino irritabile. 331
Randomised controlled trial of mesalazine in IBS 316
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 312
Chronic intestinal pseudo-obstruction related to viral infections. 301
Molecular and Pathological characterization of a non-aganglionic congenital megacolon in the rabbit 296
Il sistema nervoso enterico. 289
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 258
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 257
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 252
Use of macrogol 4000 in chronic constipation. 243
Diagnosis and therapy of irritable bowel syndrome 240
Sigmoid compliance and visceral perception in spinal cord injury patients 240
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 239
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 236
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 235
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 229
Basis for treatment of functioning neuroendocrine tumours. 227
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 224
Chromogranin A: is it a useful marker of neuroendocrine tumors? 222
L’encefalomiopatia Mitocondriale Neurogastrointestinale (MNGIE): Il Fegato Come Nuova Fonte Di Timidina Fosforilasi 218
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 218
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 217
Endocrine pancreatic tumors: factors correlated with survival. 216
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 215
The immune system in irritable bowel syndrome. 215
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 214
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 212
A case of primary pancreatic lymphoma. 210
New insights into human enteric neuropathies. 205
Chronic intestinal pseudo-obstruction. 204
MALATTIA DA REFLUSSO GASTROESOFAGEO 202
Duodenal histology in patients with celiac disease after a gluten-free diet 197
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 196
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 195
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 192
Expression and regulation of α-transducin in the pig gastrointestinal tract 191
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 190
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 187
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 186
Interstitial lung disease (ILD) and gastroesophageal reflux (GER) 184
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. 184
Endocrine tumors of the ileum: factors correlated with survival. 184
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 183
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 182
Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge. 181
Paraneoplastic Syndrome 180
Gut microbiota and related diseases: clinical features. 180
Pancreatic involvement in systemic sarcoidosis. A case report. 179
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 179
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 179
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 179
Gastroesophageal reflux disease: therapeutic features (Part II)] 177
Post-infectious Irritable Bowel Syndrome. 177
Enteroendocrine profile of α-transducin immunoreactive cells in the gastrointestinal tract of the European sea bass (Dicentrarchus labrax) 176
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 175
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 175
Gastro-oesophageal reflux and interstitial lung disease. 173
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 171
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 170
Medical treatment of endocrine gastroenteropancreatic tumors. 170
Neuroplasticità gastroenterica: dai geni all’infiammazione. 170
Enteric neuroplasticity evoked by inflammation 170
Clinical approach to diarrhea 169
Zollinger-Ellison syndrome. Diagnosis and therapy. 168
Unsolved problems in the management of patients with gastro-oesophageal reflux disease 167
Enteric neuropathy evoked by repeated cisplatin in the rat. 167
A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. 167
Actual therapy of gastroesophageal reflux disease 165
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID). 165
Water-related techniques in colonoscopy: the end justifies the means! 164
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 164
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 164
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 163
Malattia da reflusso gastroesofageo. 162
Quality of life in patients with chronic pancreatitis 161
Chronic intestinal pseudo-obstruction. 160
Sympathetic hyperactivity in patients with ulcerative colitis. 160
Delayed gastric emptying in functional dyspepsia 159
Enteric neuron involvement in dysmotilities and responses to inflammation. 159
La malattia da reflusso gastroesofageo. 159
Sedation during colonoscopy and the benefits of lubrication 159
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 159
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 156
Inflammatory neuropathies of the enteric nervous system 156
Lubrication during colonoscopy: a forgotten factor. 156
Does colorectal endometriosis alter intestinal functions? A prospective manometric and questionnaire-based study. 155
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 155
Molecular genetics of human enteric neuropathies. 153
Quality of life and clinical indicators for chronic pancreatitis patients in a 2-year follow-up study. 153
Review article: molecular, pathological and therapeutic features of human enteric neuropathies 152
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. 152
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. 151
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (IBS-C). 151
Routine duodenal biopsies: is it time to change our minds? 150
Warm water and oil assistance in colonoscopy 150
Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. 150
Totale 21.659
Categoria #
all - tutte 86.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.401 0 0 0 0 0 0 0 0 0 155 149 1.097
2021/20224.003 524 115 237 212 274 177 78 210 110 200 1.298 568
2022/20233.852 367 535 229 483 265 254 94 244 640 124 280 337
2023/20241.338 106 190 130 121 143 351 65 54 20 44 59 55
2024/20254.541 179 591 461 254 861 323 454 260 149 201 105 703
2025/20268.881 730 945 892 620 1.163 561 1.017 312 2.054 587 0 0
Totale 33.853